SafeCare Magazine 3rd Quarter 2017
|
|
EDITORIAL BRIEF
Mending Broken Hearts
- Nearly 1 Million CABG Surgeries Performed Worldwide Annually
Sarju Bharucha, JD, Editor-in-Chief
- Nearly 1 Million CABG Surgeries Performed Worldwide Annually
Sarju Bharucha, JD, Editor-in-Chief
As we explore the various facets of medicine, there are surgeries that defy what men ever thought they could accomplish. One of these surgeries include Coronary Artery Bypass and Grafting (“CABG”). Surprisingly, each year nearly one million CABG surgeries are performed worldwide. Initially, this heart-stopping and electrifying procedure of intricately grafting to coronary arteries involved only saws, forceps, sutures, and human hands. It has now progressed to include novel technologies, including robots.
In this issue, we are bringing you an exclusive interview with Dr. Peter McKeown, MD, MBA, MPA, MPH, a Harvard educated physician leader, internationally renowned heart surgeon, and The SafeCare Group advisor to delve into the questions that probe the pros and cons of these new technologies across all facets of medicine. For example, questions such as “how big a role should technology play? How do we assess new procedures and technologies?”
In this issue, we are bringing you an exclusive interview with Dr. Peter McKeown, MD, MBA, MPA, MPH, a Harvard educated physician leader, internationally renowned heart surgeon, and The SafeCare Group advisor to delve into the questions that probe the pros and cons of these new technologies across all facets of medicine. For example, questions such as “how big a role should technology play? How do we assess new procedures and technologies?”
COVER STORY TRANSCRIPT
Mending Broken Hearts
Nearly one million CABG surgeries are performed worldwide annually - what is the future of heart surgery?
Full, in-depth interview by The SafeCare Group CEO & Chairman Yisrael M. Safeek, MD, MBA with Harvard-trained heart surgeon and The SafeCare Group advisor Peter McKeown, MD, MBA, MPA, MPH.
Yisrael Safeek: Welcome Dr. McKeown. You are a Harvard educated physician leader and internationally renowned heart surgeon. Since 2015, you have served as a patient safety advisor for The SafeCare Group, and I thank you for serving. Before that, you served as Deputy Chief Medical Officer for the VA Mid-South Healthcare Network and Executive Director of Asheville Medical Research and Education Corporation (AMREC), as well as Cardiothoracic Surgery Program Director of a Cleveland Clinic Affiliated program. Your faculty appointments included Professor of Surgery, Division of Cardiovascular and Thoracic Surgery, University of South Florida, Professor of Surgery and Head of School, University of New England, Australia, serving as Deputy Dean of Joint Medical Program, and Conjoint Professor School of Medicine and Public Health, University of Newcastle. You are the author of over 100 publications and several book chapters and a former Board Member of the American Heart Association and American College of Chest Physicians. You are a fellow of the American College of Healthcare Executives, the American Board of Thoracic Surgery, and the American College of Surgeons. How about you telling our readers about your education and training?
Peter McKeown: I went to medical school in Australia at the University of Queensland and did an internship at the Royal Brisbane Hospital, before moving to San Francisco to do a general surgery residency at St. Mary’s Hospital. This was followed by a vascular surgery fellowship at Stanford University and then cardiothoracic surgery residency at Emory University in Atlanta. In 1988, I did a sabbatical year in London with Dr. Marc de Laval and Professor Sir Magdi Yacoub in congenital cardiac surgery and heart and heart lung transplantation. During that year I also had the opportunity to visit major cardiac surgery centers in Paris, Rome, Melbourne and Rotterdam. In 1998 to 1999, with support from the Society of Thoracic Surgeons (STS) with an Alley Sheridan Scholarship I was able to do a sabbatical year at Harvard University, doing a Masters in Public Health in clinical effectiveness and a Masters in Public Administration from the Kennedy School of Government in Healthcare policy and Healthcare leadership. I consider myself very fortunate to have had all these many wonderful opportunities.
Nearly one million CABG surgeries are performed worldwide annually - what is the future of heart surgery?
Full, in-depth interview by The SafeCare Group CEO & Chairman Yisrael M. Safeek, MD, MBA with Harvard-trained heart surgeon and The SafeCare Group advisor Peter McKeown, MD, MBA, MPA, MPH.
Yisrael Safeek: Welcome Dr. McKeown. You are a Harvard educated physician leader and internationally renowned heart surgeon. Since 2015, you have served as a patient safety advisor for The SafeCare Group, and I thank you for serving. Before that, you served as Deputy Chief Medical Officer for the VA Mid-South Healthcare Network and Executive Director of Asheville Medical Research and Education Corporation (AMREC), as well as Cardiothoracic Surgery Program Director of a Cleveland Clinic Affiliated program. Your faculty appointments included Professor of Surgery, Division of Cardiovascular and Thoracic Surgery, University of South Florida, Professor of Surgery and Head of School, University of New England, Australia, serving as Deputy Dean of Joint Medical Program, and Conjoint Professor School of Medicine and Public Health, University of Newcastle. You are the author of over 100 publications and several book chapters and a former Board Member of the American Heart Association and American College of Chest Physicians. You are a fellow of the American College of Healthcare Executives, the American Board of Thoracic Surgery, and the American College of Surgeons. How about you telling our readers about your education and training?
Peter McKeown: I went to medical school in Australia at the University of Queensland and did an internship at the Royal Brisbane Hospital, before moving to San Francisco to do a general surgery residency at St. Mary’s Hospital. This was followed by a vascular surgery fellowship at Stanford University and then cardiothoracic surgery residency at Emory University in Atlanta. In 1988, I did a sabbatical year in London with Dr. Marc de Laval and Professor Sir Magdi Yacoub in congenital cardiac surgery and heart and heart lung transplantation. During that year I also had the opportunity to visit major cardiac surgery centers in Paris, Rome, Melbourne and Rotterdam. In 1998 to 1999, with support from the Society of Thoracic Surgeons (STS) with an Alley Sheridan Scholarship I was able to do a sabbatical year at Harvard University, doing a Masters in Public Health in clinical effectiveness and a Masters in Public Administration from the Kennedy School of Government in Healthcare policy and Healthcare leadership. I consider myself very fortunate to have had all these many wonderful opportunities.
PREVIEW SAFECARE ONLINE
Printing is not available through the online version.
BLANK PILLS
Blank pills in simple language refer to counterfeit (fake) medications that are manufactured, distributed, and sold through criminal channels. According to the Food and Drug Administration (FDA), 20% of all medications sold are blank pills, and in parts of Africa and Asia this figure exceeds 50%. Counterfeit medicines are not equivalent in quality, safety, and efficacy to authentic drug regimens.
SMART SURGICAL DEVICES
IMPROVING QUALITY OF HEALTHCARE
SPONSORS
